Reviewnpj antimicrobials and resistance2025

An Australian perspective on clinical, economic and regulatory considerations in emerging nanoparticle therapies for infections.

Benjamin W Muir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.